Login to your account

Username *
Password *
Remember Me

Patients, clinicians seek answers to the mystery of ‘Long COVID’

Patients, clinicians seek answers to the mystery of ‘Long COVID’ – CIDRAP  

The post Patients, clinicians seek answers to the mystery of ‘Long COVID’ appeared first on Links Medicus.

Clinical update: Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine – JAMA Author interview: COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions  

The post Clinical update: Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine appeared first on Links Medicus.

Large cohort study identifies the most common hospital complications associated with COVID-19

Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study – Canadian Medical Association Journal Commentaries: Analysis of patient data reveals most common complications of COVID-19 – Medical News Today AND Study confirms most common complications associated with COVID-19 – New Medical   Commentary on Twitter Large study of patients in the US who contracted #COVID19 confirms […]

The post Large cohort study identifies the most common hospital complications associated with COVID-19 appeared first on Links Medicus.

Airborne transmission of SARS-CoV-2: What we know

Airborne Transmission of SARS-CoV-2: What We Know – Clinical Infectious Diseases   Commentary on Twitter Our workshop summary on airborne transmission of SARS-CoV-2 is out. Thanks to all the leading scientists who helped lead this amazing and impactful workshop! @theNASEM @linseymarr @kprather88 @Lakdawala_Lab https://t.co/MKfNA0QatN — John Volckens (@Smogdr) January 18, 2021  

The post Airborne transmission of SARS-CoV-2: What we know appeared first on Links Medicus.

[News release – Not published yet] Lilly’s neutralizing antibody prevented COVID-19 at nursing homes, reducing risk by up to 80 percent for residents

Lilly’s neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial, reducing risk by up to 80 percent for residents Commentaries: Eli Lilly says its monoclonal antibody prevented Covid-19 infections in clinical trial – STAT AND Expert reaction to press release from Lilly about their neutralising antibody bamlanivimab and results from the […]

The post [News release – Not published yet] Lilly’s neutralizing antibody prevented COVID-19 at nursing homes, reducing risk by up to 80 percent for residents appeared first on Links Medicus.

Randomized trial: Similar outcomes with lower vs. higher oxygenation targets for acute hypoxemic respiratory failure

Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure – New England Journal of Medicine (link to abstract – $ for full-text)   Commentary on Twitter Even though supplemental oxygen is used for the treatment of patients with hypoxemic respiratory failure, the most effective oxygenation targets are not known. In this randomized trial, a […]

The post Randomized trial: Similar outcomes with lower vs. higher oxygenation targets for acute hypoxemic respiratory failure appeared first on Links Medicus.

Meta-analysis: saliva and nasopharyngeal swab nucleic acid amplification have similar diagnostic accuracy for the detection of SARS-CoV-2

Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis – JAMA Internal Medicine Related: The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs: A Systematic Review and Meta-analysis – Annals of Internal Medicine  

The post Meta-analysis: saliva and nasopharyngeal swab nucleic acid amplification have similar diagnostic accuracy for the detection of SARS-CoV-2 appeared first on Links Medicus.

Covid-19: What new variants are emerging and how are they being investigated?

Covid-19: What new variants are emerging and how are they being investigated? – The BMJ  

The post Covid-19: What new variants are emerging and how are they being investigated? appeared first on Links Medicus.

New calculator identifies COVID-19 patients at highest risk of deterioration

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study – The Lancet Respiratory Medicine Commentaries: Improving clinical management of COVID-19: the role of prediction models – The Lancet Respiratory Medicine Tool identifies COVID-19 patients at highest risk of deterioration – UK Research and Innovation See calculator: […]

The post New calculator identifies COVID-19 patients at highest risk of deterioration appeared first on Links Medicus.

IDSA: COVID-19 Diagnostic Guidelines Updates

COVID-19 Diagnostic Guidelines Updates (Jan. 16, 2021) – Infectious Diseases Society of America  

The post IDSA: COVID-19 Diagnostic Guidelines Updates appeared first on Links Medicus.

Recherche